Day: July 22, 2021

PRESS RELEASE AB SCIENCE TO PRESENT RESULTS FROM ITS PHASE III AB09004 STUDY IN MILD TO MODERATE ALZHEIMER’S DISEASE AT THE WORLD’S LARGEST CONFERENCE FOR ALZHEIMER’S AND DEMENTIA RESEARCH (AAIC 2021) Paris, 22 July, 2021, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced that an abstract reporting results from its Phase 3 AB09004 study on Alzheimer’s disease has been selected for an oral presentation at the annual Alzheimer’s Association International Conference (AAIC) (July 26-30, 2021). The AAIC is the largest and most influential international meeting dedicated to the latest Alzheimer’s and dementia research. Last year’s virtual conference event attracted over 31,000 registered attendees and more than 3,000 scientific presentations. This year the Alzheimer’s Association International Conference...

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,517,943,476 €Registered office : 54, rue La Boétie – 75008 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844Date   Total number of issued shares   Number of real voting rights(excluding treasury shares) Theoretical number of voting rights (including treasury shares)*June 30, 2021 1,260,785,780 1,409,524,377 1,417,776,950* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers. This...

PUBLICATION OF A TRANSPARENCY NOTIFICATION IN ACCORDANCE WITH THE LAW OF 02/05/2007 ON THE DISCLOSURE OF IMPORTANT PARTICIPATIONS A notification of 20 July 2021 issued by Ackermans & van Haaren NV shows that both a passive threshold overrun and an acquisition of voting securities took place, following the introduction of the double voting rights and a capital increase by contribution in kind from a/o Extensa Group, as approved at the extraordinary general meeting of Leasinvest Real Estate on 19 July 2021. The total number of voting rights of Ackermans & van Haaren NV in Leasinvest Real Estate has increased, so that Ackermans & van Haaren NV now holds 64.66% of the voting rights in Leasinvest Real Estate NV (hereinafter the “Company”). The notification comprises the following information: REASON FOR THE NOTIFICATION:...

First-half 2021 revenue   Strong recovery across all activities Q2 revenue: €186.8 M (+25.1% at CER1) First-half revenue: €363.1 M (+9.6% at CER) Confirmation of our objective of a return to growth in 2021Villepinte, July 22, 2021 – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting its revenue for the first half of 2021. As of June 30, 2021, it was €363.1 million, stable compared with June 30, 2020 (€363.7 million), and including an unfavourable forex impact of €17.2 million. Excluding forex effects and on a like-for-like basis, revenue was up 9.6% from June 30, 2020. After a Q1 down 2021, Q2 of the fiscal year is characterized by the return to growth across all Group product lines with, on a like-for-like basis, sales up by 25.1% excluding forex effects. As a reminder,...

Improvement in gross margin in H1 2021 H1 2021 gross margin: €40.3m, up 18% at constant currency rate Q2 2021 gross margin: Acceleration in growth in Q2 2021,up 25% at constant currency rate 2021 gross margin guidance revised up to around €85mand EBITDAr1 target of between 22% and 25% maintained Paris, July 22, 2021 – 5.45pm CEST – Artefact (FR0000079683 – ALATF – eligible for PEA-PME equity savings plans), an expert in data transformation for major brands, today announced its gross margin in H1 2021 and revised up its 2021 gross margin guidance to around €85m. Guillaume de Roquemaurel and Vincent Luciani, Artefact’s Co-CEOs, commented: “Our highly positive business momentum indicators for H1 2021 reflect Artefact’s strategic positioning, which harnesses our data services and our cutting-edge AI expertise to support the digitalisation...

Second Quarter 2021 HighlightsNet Income: Net income totaled $6.4 million for the quarter ended June 30, 2021, or $1.10 per diluted common share compared to net income of $3.5 million or $0.59 per diluted common share for the quarter ended June 30, 2020. Net income totaled $12.7 million for the six months ended June 30, 2021, or $2.17 per diluted common share compared to net income of $6.2 million or $1.05 per diluted common share for the six months ended June 30, 2020. Overall Profitability: This is the third consecutive quarter of record return on average assets (“ROAA”) performance for the Company. The Company’s ROAA and return on average common equity (“ROACE”) were 1.22% and 12.62% for the three months ended June 30, 2021 compared to 0.69% and 7.27% for the three months ended June 30, 2020. The Company’s...

Saint-Cloud, 22 July 2021 Availability of the 2021 first half-year Financial Report as of 30 June 2021 DASSAULT AVIATION 2021 first half-year Financial Report (Rapport Financier Semestriel) as of 30 June 2021 is available to the public and has been filed with the French Financial Markets Authority (Autorité des Marchés Financiers). This financial report can be found on the company’s website at www.dassault-aviation.com, in the “Finance / Regulated information / 2021” section.AttachmentAvailability of the 2021 first half-year Financial Report

Press release Paris La Défense, 22 July 2021 Great success of the capital increase reserved for employees Albioma is announcing that it has successfully completed its second capital increase reserved for members of the Group savings plan (Albioma Invest 2021). More than 48% of eligible employees and former employees subscribed to the operation, the precise terms of which were made public in a press release dated 5 May 2021. The capital increase, which was oversubscribed, resulted in the issue, at a unit price of €24.48 (corresponding to 70% of the reference price), of 197,386 new shares representing 0.62% of the share capital. It will bring the stake of the Albioma FCPE to approximately 1.5% of the share capital. The shares, which carry current dividend rights, were admitted today to trading on Euronext Paris. Frédéric Moyne, Chairman...